Literature DB >> 16356424

Risk of death for children with down syndrome and sepsis.

Michelle M Garrison1, Howard Jeffries, Dimitri A Christakis.   

Abstract

OBJECTIVE: To determine differences in case fatality rates between children with and without Down syndrome. STUDY
DESIGN: We used the Pediatric Health Information System (PHIS) database, which includes demographic and diagnostic data from freestanding children's hospitals. Using Poisson regression, we determined the risk of mortality from sepsis for children with Down syndrome, after controlling for potential confounding factors.
RESULTS: A total of 35,645 patients met our inclusion criteria, of which 3936 (11%) died during hospitalization. Altogether, 620 of the included patients also had a diagnosis of Down syndrome; 106 (17%) of these died during hospitalization. Children with Down syndrome had significantly elevated risk of mortality (mortality rate ratio = 1.30; 95% confidence interval = 1.06 to 1.59) after adjusting for potential confounding factors including demographics, pathogens, and concomitant conditions.
CONCLUSIONS: Children with Down syndrome and sepsis have elevated risk of mortality. These findings have implications for treatment decisions, communications about prognosis, and future research.

Entities:  

Mesh:

Year:  2005        PMID: 16356424     DOI: 10.1016/j.jpeds.2005.06.032

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.

Authors:  Elizabeth G Salazar; Yimei Li; Brian T Fisher; Susan R Rheingold; Julie Fitzgerald; Alix E Seif; Yuan-Shung Huang; Rochelle Bagatell; Richard Aplenc
Journal:  Br J Haematol       Date:  2016-05-10       Impact factor: 6.998

2.  Proportion of malformations and genetic disorders among cases encountered at a high-care unit in a children's hospital.

Authors:  Akiko Soneda; Hideki Teruya; Noritaka Furuya; Hiroshi Yoshihashi; Keisuke Enomoto; Aki Ishikawa; Kiyoshi Matsui; Kenji Kurosawa
Journal:  Eur J Pediatr       Date:  2011-07-16       Impact factor: 3.183

Review 3.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

4.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

5.  Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency?

Authors:  Avni Y Joshi; Roshini S Abraham; Melissa R Snyder; Thomas G Boyce
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

Review 6.  Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

Authors:  Ana C Xavier; Yubin Ge; Jeffrey W Taub
Journal:  J Mol Diagn       Date:  2009-09       Impact factor: 5.568

7.  Down syndrome, autoimmunity and T regulatory cells.

Authors:  F P Pellegrini; M Marinoni; V Frangione; A Tedeschi; V Gandini; F Ciglia; L Mortara; R S Accolla; L Nespoli
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

8.  Clinical course and outcome for critically ill children with Down syndrome: a retrospective cohort study.

Authors:  Shane M Tibby; Andrew Durward; Chong Tien Goh; Kentigern Thorburn; Kevin Morris; Mike Broadhead; Mark J Peters
Journal:  Intensive Care Med       Date:  2012-05-15       Impact factor: 17.440

Review 9.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

Review 10.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.